Filing Details
- Accession Number:
- 0001209191-23-049519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-14 20:18:41
- Reporting Period:
- 2023-09-13
- Accepted Time:
- 2023-09-14 20:18:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559583 | W John Smither | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-13 | 900 | $20.78 | 6,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
